c-Rel inhibitors (Cornell University)

N/A

Report date: 2025/03/19 08:58:59
NME

Base Information

Drug Namec-Rel inhibitors (Cornell University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene c-Rel inhibitors
TargetsProto-oncogene c-Rel
Therapy Area/IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCornell University
China Registration ClassN/A

Develop Information

Active CompaniesCornell University
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A